Back to News
Market Impact: 0.5

Asia-Pacific markets mostly lower following Wall Street losses ahead of Fed rate decision

NVDA
Monetary PolicyInterest Rates & YieldsInvestor Sentiment & PositioningMarket Technicals & FlowsSanctions & Export ControlsTechnology & InnovationEmerging Markets
Asia-Pacific markets mostly lower following Wall Street losses ahead of Fed rate decision

Asia‑Pacific equities opened mostly lower as investors positioned ahead of the U.S. Federal Reserve's Dec. 10 meeting, where a 25bp cut to a 3.50%–3.75% target range is widely anticipated but the Fed is expected to adopt a more data‑dependent stance. Major APAC moves included the Nikkei down 0.29%, Topix down 0.17%, Kospi down 0.32% and ASX 200 down 0.43%, while U.S. futures were slightly higher after President Trump approved limited Nvidia H200 chip sales to China (Nvidia +2.2% after‑hours) under terms that funnel 25% of sales to the U.S. government; overnight U.S. indices weakened (S&P -0.35%, Nasdaq -0.14%, Dow -0.45%).

Analysis

Market structure: The Nvidia H200 China approval (with a 25% payment to the U.S.) is a net positive for NVDA demand but reduces per-unit economics; expect meaningful volume uplift in China that should boost NVDA revenue growth by mid-2025 even if gross margin impact trims 3–7 percentage points on China sales. Winners: NVDA, approved Chinese cloud/data-center customers, and U.S. government receipts; losers: smaller GPU competitors (AMD) and any upstream suppliers that lose allocation to Nvidia-centric supply chains. Cross-asset: a priced-in 25bp Fed cut (Dec 10) should lower short-end yields and steepen curves transiently, benefiting duration and risk assets; implied vol for NVDA should compress after the announcement but spike on implementation details and customer list releases. Risk assessment: Tail risks include US policy reversal or retroactive restrictions, China retaliatory measures, or limited “approved” customer lists that cap TAM — low probability but >10% impact to revenue. Time horizons: immediate (days) expect a 1–5% NVDA move; short-term (weeks) flow into semis and software, and medium-term (3–12 months) structural demand for AI chips. Hidden dependency: approval mechanics and revenue-share enforcement logistics (who pays the 25%) and whether NVDA will raise ASPs to offset the levy. Catalysts to watch: Dec 10 Fed wording, Nvidia earnings/guide, first approved-customer names (30–60 days), China hyperscaler capex windows. Trade implications: Tactical long NVDA exposure (options or equity) to capture China demand and near-term sentiment around Dec 10; pair-trade long NVDA/short AMD to express GPU share shift. Use defined-cost option structures (calendar or vertical spreads) around Fed and customer-list windows to limit theta. Rotate 2–4% portfolio weight from low-volatility defensive names into semiconductors and data-center hardware over 2–8 weeks if Fed cuts and NVDA customer disclosures are constructive. Contrarian angles: Consensus overlooks that the 25% payment sets a precedent (future approvals could carry higher levies) and that approved-customer bottlenecks could concentrate demand but defer revenue recognition; the market may underprice margin compression versus volume upside. The positive price reaction could be overdone if implementation is slow — a 8–12% pullback in NVDA post-initial euphoria is a realistic buying opportunity. Historical parallel: partial-lift sanctions (e.g., partial Huawei access windows) led to front-loaded orders followed by troughs; expect similar lumpy demand patterns.